BRIEF-BiondVax – Last Of 12,400 Participants Completes Final Visit In Biondvax’s M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial

BRIEF-BiondVax – Last Of 12,400 Participants Completes Final Visit In Biondvax’s M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
Advertisement

July 1 (Reuters) – BiondVax Pharmaceuticals Ltd:

* LAST OF 12,400 PARTICIPANTS COMPLETES FINAL VISIT IN BIONDVAX’S M-001 UNIVERSAL FLU VACCINE PIVOTAL PHASE 3 CLINICAL TRIAL

* BIONDVAX PHARMACEUTICALS – EQUIPMENT INSTALLATION, MANUFACTURING PROCESS SCALE-UP IN BIONDVAX’S PILOT FACILITY IN JERUSALEM ARE IN PROGRESS Source text for Eikon: Further company coverage:

Advertisement
Our Correspondent

Our Correspondent

Related Articles

A land of opportunity is Balochistan.

A land of opportunity is Balochistan.

A Pakistani man was imprisoned for filming his sister’s “honor” killing.

A Pakistani man was imprisoned for filming his sister’s “honor” killing.

Ismail al-Zin, the commander of Hezbollah, was slain by the Israeli forces.

Ismail al-Zin, the commander of Hezbollah, was slain by the Israeli forces.

Role of ISKP in the terror assault in Moscow linked to Pakistan’s deep state

Role of ISKP in the terror assault in Moscow linked to Pakistan’s deep state

In Balochistan, a roof collapse caused by heavy rain claimed the lives of five miners.

In northwest Pakistan, landslides and heavy rains claim seven lives.

In northwest Pakistan, landslides and heavy rains claim seven lives.